a
a
Weather:
No weather information available
HomeHealthLeucid Bio Announces Treatment of First Patient in AERIAL Trial of NKG2D CAR-T Therapy LEU011 for Solid Tumours

Leucid Bio Announces Treatment of First Patient in AERIAL Trial of NKG2D CAR-T Therapy LEU011 for Solid Tumours

Initiation of AERIAL trial accelerated by successful first close of Series A1 financing LEU011 is first CAR-T candidate for the treatment of solid tumours to be manufactured at Great Ormond Street Hospital (GOSH) Enrolment continues in AERIAL trial with initial data for LEU011 expected in…

No comments

Sorry, the comment form is closed at this time.

Translate »